156 related articles for article (PubMed ID: 28223795)
21. Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo.
Zhu Q; Pan X; Sun Y; Wang Z; Liu F; Li A; Zhao Z; Wang Y; Li K; Mi L
PLoS One; 2017; 12(10):e0185507. PubMed ID: 28985230
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
23. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
24. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma.
Lang M; Wang X; Wang H; Dong J; Lan C; Hao J; Huang C; Li X; Yu M; Yang Y; Yang S; Ren H
Cancer Lett; 2016 Aug; 378(2):87-96. PubMed ID: 27212442
[TBL] [Abstract][Full Text] [Related]
25. Moscatilin induces apoptosis of pancreatic cancer cells via reactive oxygen species and the JNK/SAPK pathway.
Zhang L; Fang Y; Xu XF; Jin DY
Mol Med Rep; 2017 Mar; 15(3):1195-1203. PubMed ID: 28138710
[TBL] [Abstract][Full Text] [Related]
26. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
Kimura F; Kawamura J; Watanabe J; Kamoshida S; Kawai K; Okayasu I; Kuwao S
Diagn Cytopathol; 2010 Mar; 38(3):161-7. PubMed ID: 19821496
[TBL] [Abstract][Full Text] [Related]
27. Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma.
Tang Q; Lu M; Chen D; Liu P
Int J Nanomedicine; 2015; 10():7129-43. PubMed ID: 26604760
[TBL] [Abstract][Full Text] [Related]
28. Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles.
Wang L; Dong J; Ouyang W; Wang X; Tang J
Oncol Rep; 2012 Mar; 27(3):719-26. PubMed ID: 22134718
[TBL] [Abstract][Full Text] [Related]
29. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
[TBL] [Abstract][Full Text] [Related]
30. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
31. Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression.
Tang QS; Zhang DS; Cong XM; Wan ML; Jin LQ
Biomaterials; 2008 Jun; 29(17):2673-9. PubMed ID: 18396332
[TBL] [Abstract][Full Text] [Related]
32. Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.
Harima H; Kaino S; Takami T; Shinoda S; Matsumoto T; Fujisawa K; Yamamoto N; Yamasaki T; Sakaida I
BMC Cancer; 2016 Aug; 16(1):702. PubMed ID: 27582255
[TBL] [Abstract][Full Text] [Related]
33. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate-coupled nanoparticles and magnetic nanochemothermia for the relapse-free treatment of T24 bladder tumors.
Stapf M; Teichgräber U; Hilger I
Int J Nanomedicine; 2017; 12():2793-2811. PubMed ID: 28435259
[TBL] [Abstract][Full Text] [Related]
35. Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells.
Warner SL; Stephens BJ; Nwokenkwo S; Hostetter G; Sugeng A; Hidalgo M; Trent JM; Han H; Von Hoff DD
Clin Cancer Res; 2009 Nov; 15(21):6519-28. PubMed ID: 19861455
[TBL] [Abstract][Full Text] [Related]
36. [Abnormality of TOP2A expression and its gene copy number variations in neuroblastic tumors].
Chen JM; Zhou CJ; Ma XL; Guan DD; Yang LY; Yue P; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):748-754. PubMed ID: 27821228
[No Abstract] [Full Text] [Related]
37. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.
Shi Y; Sahu RP; Srivastava SK
BMC Cancer; 2008 Oct; 8():294. PubMed ID: 18847491
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Nambiar D; Prajapati V; Agarwal R; Singh RP
Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268
[TBL] [Abstract][Full Text] [Related]
39. TPX2 promotes cell proliferation and migration via PLK1 in OC.
Ma S; Rong X; Gao F; Yang Y; Wei L
Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
[TBL] [Abstract][Full Text] [Related]
40. Cell proliferation index determination by immunohistochemical detection of hCDC47 protein.
Rojiani MV; Siemann DW; Rojiani AM
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):278-82. PubMed ID: 20048674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
